<img height="1" width="1" src="https://www.facebook.com/tr?id=1475348972529988&amp;ev=PageView &amp;noscript=1">
Home
About
Why Milton Park?
Getting Here
Availability
News & Events
Work Here
Downloads
Contact Us

Adaptimmune Limited

60 Jubilee Avenue
Milton Park
Abingdon
Oxfordshire
OX14 4RX

With a research base in Oxford, UK and a clinical base in Philadelphia, US, Adaptimmune is focused on the use of T cell therapy to treat cancer. It aims to utilise the body’s own machinery – the T cell – to target and destroy cancerous by using engineered, increased affinity T cell receptors (TCRs) as a means of strengthening natural patient T cell responses.


Add or update Company

Submission Terms and Conditions

Terms and conditions for submitting an event, news story or company onto Milton Park’s website: www.miltonpark.co.uk

  1. miltonpark.co.uk is owned and run by MEPC Ltd, owners and managers of Milton Park, Oxfordshire
  2. All submissions are forwarded to the Marketing Executive for approval before upload
  3. Content submitted may be subject to change
  4. Content must be written in good English and grammatically correct
  5. If the submission is not deemed suitable or relevant it will not be uploaded
  6. Content must be clear, easy to read, understandable and relevant to the occupiers of Milton Park
  7. Once uploaded, items are subject to deletion at any time
  8. Upon submission, you will receive a confirmation email with a copy of these terms and conditions for reference
  9. Upon submission, items will be uploaded within 3 working days if suitable
  10. Classifieds are deleted after six months of upload
  11. News stories are archived monthly and remain on the Website for one year
  12. Events are archived monthly and remain on the Website for one year
  13. Companies listed on the website will be removed when leaving Milton Park